Rhythm Biosciences Ltd has released a press release.
RHYs Four Antibodies Pass all Three Key Screening Tests
Filed with ASX ·
6ix hasn’t read this filing yet.
Rhythm Biosciences Limited on 6ix
Earlier from Rhythm Biosciences
- Reagent Development Update
- Appendix 4D - Half Yearly Report
- Rhythm reports reagent development update
- Quarterly report and Appendix 4C
- CSIRO and Rhythm Commence Development of Key Reagents
Later from Rhythm Biosciences
- Rhythm Granted Biomarker Patent in Europe
- Rhythm completes cloning of key reagent ahead of schedule
- Final Antibody Selection Complete
- AGM Presentation
- Appointment of CEO - Senior Management Changes
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences